Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...
Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...
Detailed price information for Kyverna Therapeutics Inc (KYTX-Q) from The Globe and Mail including charting and trades.
The UK Ministry of Defence (MoD) has confirmed plans to axe the Royal Navy's (RN's) projected Type 83 destroyer programme and ...
Interesting Engineering on MSN
From S-500 to THAAD: These are seven of the world’s most advanced air defense systems
Air defense has become one of the defining military technologies of our times. From ...
With more than 50 million redeemed miles under her belt, Becky Pokora is a rewards travel expert. She's been writing about credit cards and reward travel since 2011 with articles on Forbes Advisor, ...
Rheumatic and musculoskeletal diseases (RMDs) contribute significantly to the disability and health care burden in Europe, but until now there has been no harmonized, specific data set to help ...
Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
The nonbiologic DMARD leflunomide was approved for use in the treatment of rheumatoid arthritis in 1998. After being in use for more than a decade, which has also seen the introduction of highly ...
EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results